STOCK TITAN

Atlanta Braves Holdings EVP sells 186,588 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Atlanta Braves Holdings, Inc. reported that EVP, Development Michael P. Plant exercised options for and sold Series C Common Stock from November 9 through November 11, 2026. He exercised options for 57,395 shares on November 9 and 57,000 shares on each of November 10 and 11 at $27.18 per share, then sold the corresponding directly held shares at weighted-average prices of $51.28 (range $50.43–$52.04), $52.21 (range $51.57–$52.62), and $51.79 (range $51.36–$52.13), respectively. The three direct sales were effected pursuant to a Rule 10b5-1 sales plan adopted August 7, 2026. A separate sale covered 15,193 shares held indirectly through a Grantor Retained Annuity Trust, at $52 per share. Total reported sales were 186,588 shares.

Insider Plant Michael P.
Role EVP, Development
Sold 186,588 shs ($9.66M)
Approx. gross sale proceeds $9.66M
Approx. exercise cost $4.66M
Type Security Shares Price Value
Exercise Stock option (Right to Buy) - BATRK F2 57,000 $0.00 $0.00
Exercise Series C Common Stock 57,000 $27.18 $1.55M
Sale Series C Common Stock F2, F5 57,000 $51.79 $2.95M
Sale Series C Common Stock F1 15,193 $52.00 $790K
Exercise Stock option (Right to Buy) - BATRK F2 57,000 $0.00 $0.00
Exercise Series C Common Stock 57,000 $27.18 $1.55M
Sale Series C Common Stock F2, F4, F1 57,000 $52.21 $2.98M
Exercise Stock option (Right to Buy) - BATRK F2 57,395 $0.00 $0.00
Exercise Series C Common Stock F1 57,395 $27.18 $1.56M
Sale Series C Common Stock F2, F3 57,395 $51.28 $2.94M
Holdings After Transaction: Stock option (Right to Buy) - BATRK — 114,000 options (Direct); Series C Common Stock — 285,903 shares (Direct); Series C Common Stock — 0 shares (Indirect, By Grantor Retained Annuity Trust)
Holdings Before and After: Stock option (Right to Buy) - BATRK, 285,395 to 114,000 options (Direct); Series C Common Stock, 15,193 to 0 shares (Indirect, By Grantor Retained Annuity Trust)
Footnotes (5)
  1. F1. Includes (i) 23,925 shares of Series C Common Stock previously held indirectly by the reporting person through his Grantor Retained Annuity Trust ("GRAT") and subsequently returned to him in satisfaction of the GRAT's annuity obligation on December 7, 2023, that were inadvertently not reflected in the reporting person's previously reported holdings, and (ii) 16,385 shares of Series C Common Stock previously held indirectly by the reporting person through his GRAT and subsequently returned to the reporting person in satisfaction of the GRAT's annuity obligation on November 10, 2026.
  2. F2. The sales reported in this Form 4 and identified by this footnote were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 7, 2026.
  3. F3. Reflects the weighted average sale price. The range of prices for such transaction is $50.43 to $52.04. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
  4. F4. Reflects the weighted average sale price. The range of prices for such transaction is $51.57 to $52.62. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
  5. F5. Reflects the weighted average sale price. The range of prices for such transaction is $51.36 to $52.13. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
Reported shares sold 186,588 shares Aggregate reported sales from November 9 through November 11, 2026
Options exercised 171,395 shares Exercised from November 9 through November 11, 2026
Option exercise price $27.18 per share Price for the reported option exercises
November 9 exercise-and-sale 57,395 shares at weighted-average $51.28 per share Sale-price range: $50.43 to $52.04
November 10 exercise-and-sale 57,000 shares at weighted-average $52.21 per share Sale-price range: $51.57 to $52.62
November 11 exercise-and-sale 57,000 shares at weighted-average $51.79 per share Sale-price range: $51.36 to $52.13
Trust-held shares sold 15,193 shares at $52 per share Shares held indirectly through a Grantor Retained Annuity Trust, November 11, 2026
Rule 10b5-1 sales plan financial
"sales were effected pursuant to a Rule 10b5-1 sales plan"
Grantor Retained Annuity Trust financial
"shares held indirectly through a Grantor Retained Annuity Trust"
A grantor retained annuity trust (GRAT) is an estate-planning tool where the person who creates the trust transfers assets into it but receives fixed cash payments (an annuity) from the trust for a set number of years; whatever remains after that term passes to designated beneficiaries. It matters to investors because it can shift future appreciation of assets out of the creator’s taxable estate—like putting an asset into a timed vending machine that pays you fixed amounts while any extra value that grows inside the machine goes to heirs with reduced gift or estate tax consequences.
weighted average sale price financial
"Reflects the weighted average sale price"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did Atlanta Braves Holdings (BATRA) EVP, Development Michael P. Plant sell?

Michael P. Plant reported selling 186,588 Series C shares from November 9 through November 11, 2026. Direct sales were 57,395 shares at a weighted-average $51.28 on November 9, 57,000 at $52.21 on November 10, and 57,000 at $51.79 on November 11. A separate sale covered 15,193 trust-held shares at $52 per share.

How many shares remained in the trust after the Atlanta Braves Holdings (BATRA) transaction?

The reported position held indirectly through the Grantor Retained Annuity Trust was 0 shares after the November 11, 2026 sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Plant Michael P.

(Last)(First)(Middle)
C/O ATLANTA BRAVES HOLDINGS, INC.
755 BATTERY AVENUE SE

(Street)
ATLANTA GEORGIA 30339

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Atlanta Braves Holdings, Inc. [ BATRK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP, Development
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/09/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Series C Common Stock11/09/2026M57,395A$27.18326,913(1)D
Series C Common Stock11/09/2026S(2)57,395D$51.28(3)269,518D
Series C Common Stock11/10/2026M57,000A$27.18326,518D
Series C Common Stock11/10/2026S(2)57,000D$52.21(4)285,903(1)D
Series C Common Stock11/11/2026M57,000A$27.18342,903D
Series C Common Stock11/11/2026S(2)57,000D$51.79(5)285,903D
Series C Common Stock11/11/2026S15,193D$520(1)IBy Grantor Retained Annuity Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock option (Right to Buy) - BATRK$27.1811/09/2026M(2)57,39512/10/202312/10/2027Series C Common Stock57,395$0228,000D
Stock option (Right to Buy) - BATRK$27.1811/10/2026M(2)57,00012/10/202312/10/2027Series C Common Stock57,000$0171,000D
Stock option (Right to Buy) - BATRK$27.1811/11/2026M(2)57,00012/10/202312/10/2027Series C Common Stock57,000$0114,000D
Explanation of Responses:
1. Includes (i) 23,925 shares of Series C Common Stock previously held indirectly by the reporting person through his Grantor Retained Annuity Trust ("GRAT") and subsequently returned to him in satisfaction of the GRAT's annuity obligation on December 7, 2023, that were inadvertently not reflected in the reporting person's previously reported holdings, and (ii) 16,385 shares of Series C Common Stock previously held indirectly by the reporting person through his GRAT and subsequently returned to the reporting person in satisfaction of the GRAT's annuity obligation on November 10, 2026.
2. The sales reported in this Form 4 and identified by this footnote were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 7, 2026.
3. Reflects the weighted average sale price. The range of prices for such transaction is $50.43 to $52.04. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
4. Reflects the weighted average sale price. The range of prices for such transaction is $51.57 to $52.62. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
5. Reflects the weighted average sale price. The range of prices for such transaction is $51.36 to $52.13. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
/s/ Greg Heller, Attorney-in-Fact11/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading